Jazz Pharmaceuticals
JAZZ · Large Cap · NYSE · Healthcare · Biotechnology
$213.90−$0.75 (-0.35%)
Market closed · opens in 2d 0hNext open: Monday, Oct 26, 9:30 AM ETFree AI brief
Get the full brief on JAZZ
Free to track. No card required. Usually ready in 10-15 minutes.
Where JAZZ sits today
Price, momentum, and the numbers behind the story.
52-week range
Low$105.00
High$261.30
Today $213.90
RSI (14)
28.3Oversold
03070100
Stocksbrew score
62/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
What Wall Street thinks
Where the analysts and the crowd stand, and what it's worth to know first.
Analyst price targets
Current price
$213.9
Lowest
$225
Median target
$300
Highest
$337
LowHigh
The business, by the numbers
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
RevenueTrend
✓ Good things about the company
Forward P/E
Favorable · 53% below avg
9.83x
Price / sales
Strong · Low price-to-sales
2.97x
Price / FCF
Strong · Cash flow supports price
8.58x
EV / EBITDA
Strong · Earnings support price
8.23x
ROIC
Strong · Excellent capital returns
17.2%
Current ratio
Strong · Good liquidity position
1.78x
⚠ Things to watch
ROE
Needs attention · Unfavorable
22.1%
How it stacks up against its peers
JAZZ against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $13.65B | 14.5 | +12.6% | 62 |
 | $10.30B | 19.6 | +19.7% | 78 |
 | $32.47B | 34.0 | +15.5% | 78 |
 | $3.83B | 11.5 | +13.5% | 78 |
 | $1.18T | 42.7 | +49.6% | 77 |